Found: 2
Select item for more details and to access through your institution.
Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 1, p. 81, doi. 10.1111/apt.17310
- By:
- Publication type:
- Article
Nitisinone causes acquired tyrosinosis in alkaptonuria.
- Published in:
- Journal of Inherited Metabolic Disease, 2020, v. 43, n. 5, p. 1014, doi. 10.1002/jimd.12229
- By:
- Publication type:
- Article